Zoetis Inc. (ZTS): Total Liabilities
$12.14B
As of 2025-12-31
$11.93B
As of 2026-06-30
+4.9%
3-year compound annual growth
+4.3%
5-year compound annual growth
+5.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.14B | +28.2% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $9.47B | +1.9% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $9.29B | -11.7% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $10.52B | +12.5% | 2024-02-13, Balance as of period end |
| 2021-12-31 | $9.36B | -4.9% | 2023-02-14, Balance as of period end |
| 2020-12-31 | $9.84B | +11.3% | 2022-02-15, Balance as of period end |
| 2019-12-31 | $8.84B | +2.9% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $8.59B | +26.4% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $6.80B | +10.6% | 2019-02-14, Balance as of period end |
| 2016-12-31 | $6.15B | -9.9% | 2018-02-15, Balance as of period end |
| 2015-12-31 | $6.82B | +29.9% | 2017-02-16, Balance as of period end |
| 2014-12-31 | $5.25B | -6.2% | 2016-02-24, Balance as of period end |
| 2013-12-31 | $5.60B | +152.0% | 2015-02-27, Balance as of period end |
| 2012-12-31 | $2.22B | n/a | 2014-03-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $12.14B | +28.2% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $25.99B | -3.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $6.98B | +13.9% |
| Viatris Inc (VTRS) | 2025-12-31 | $22.48B | -1.7% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $9.30B | +10.7% |
| Organon & Co. (OGN) | 2025-12-31 | $12.12B | -4.1% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $3.83B | +47.9% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $32.83B | -2.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.81B | +4.5% |
Compare ZTS, BHC, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗